NephroDI Therapeutics

About:

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

Description:

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.

Total Funding Amount:

$3.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2017-01-01

Founders:

Ish Khanna, Janet D. Klein, Jeff M. Sands, Ram Pillarisetti

Number of Employees:

1-10

Last Funding Date:

2024-06-11

IPO Status:

Private

Industries: